Cargando…
Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is capable of inducing the activation of NACHT, leucine-rich repeat, and pyrin domain-containing protein 3 (NLRP3) inflammasome, a macromolecular structure sensing the danger and amplifying the inflammatory response. The main product proce...
Autores principales: | Bonaventura, Aldo, Vecchié, Alessandra, Dagna, Lorenzo, Tangianu, Flavio, Abbate, Antonio, Dentali, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811745/ https://www.ncbi.nlm.nih.gov/pubmed/35113170 http://dx.doi.org/10.1007/s00011-022-01540-y |
Ejemplares similares
-
Interleukin-1 and the NLRP3 Inflammasome in Pericardial Disease
por: Vecchié, Alessandra, et al.
Publicado: (2021) -
Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications
por: Potere, Nicola, et al.
Publicado: (2022) -
The Role of NLRP3 Inflammasome in Pericarditis: Potential for Therapeutic Approaches
por: Mauro, Adolfo G., et al.
Publicado: (2021) -
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
por: Bonaventura, Aldo, et al.
Publicado: (2021) -
High-dose dexamethasone treatment for COVID-19 severe acute respiratory distress syndrome: a retrospective study
por: Vecchié, Alessandra, et al.
Publicado: (2021)